LONDON – Shares in Novo Nordisk (NYSE: NVO), maker of the wildly popular obesity drug Wegovy, were down 1.1% on
2 years ago
COPENHAGEN – UK regulators reprimanded Danish drugmaker Novo Nordisk (NYSE: NVO) for failing to disclose fees and expenses paid to
